New method estimates Epstein-Barr virus in blood using standard genome sequencing data
Medical Xpress
February 19, 2026
AI-Generated Deep Dive Summary
The Epstein-Barr virus (EBV) is a prevalent pathogen linked to various cancers and autoimmune disorders, yet understanding how the body manages this infection remains a challenge. Researchers from University Hospital Bonn (UKB) and the University of Bonn have made significant strides by developing a novel method to estimate EBV levels in blood using standard genome sequencing data, offering a non-invasive alternative to traditional virus detection techniques.
This innovative approach leverages existing genome sequencing data, originally intended for mapping human DNA, to identify viral presence. By analyzing genetic and non-genetic factors influencing EBV control, the researchers have provided deeper insights into how the immune system interacts with the virus. This breakthrough not only enhances our understanding of EBV dynamics but also paves the way for more effective monitoring and treatment strategies.
The implications of this study are profound for public health. Improved
Verticals
healthmedical
Originally published on Medical Xpress on 2/19/2026